创模生物科技(北京)有限公司

CN / En

NEWS

What are the advantages of Genetic Engineering Homology Modeling Platform of InnoModels Biotechnology?

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-16 16:23
  • Views:

(Summary description)With the rapid development of biotechnology, the field of biomedicine is ushering in an unprecedented change. In this change, InnoModels Biotechnology (Beijing) Co., Ltd. provides strong support for drug discovery, disease prevention and treatment with its unique genetic engineering homology modeling platform. The purpose of this paper is to introduce the advantages of InnoModels' genetic engineering homology modeling platform and its important role in the field of biomedicine.

What are the advantages of Genetic Engineering Homology Modeling Platform of InnoModels Biotechnology?

(Summary description)With the rapid development of biotechnology, the field of biomedicine is ushering in an unprecedented change. In this change, InnoModels Biotechnology (Beijing) Co., Ltd. provides strong support for drug discovery, disease prevention and treatment with its unique genetic engineering homology modeling platform. The purpose of this paper is to introduce the advantages of InnoModels' genetic engineering homology modeling platform and its important role in the field of biomedicine.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-16 16:23
  • Views:
Information

With the rapid development of biotechnology, the field of biomedicine is ushering in an unprecedented change. In this change, InnoModels Biotechnology (Beijing) Co., Ltd. provides strong support for drug discovery, disease prevention and treatment with its unique genetic engineering homology modeling platform. The purpose of this paper is to introduce the advantages of InnoModels' genetic engineering homology modeling platform and its important role in the field of biomedicine.
Platform Introduction:
Based on bioinformatics and genomics technologies, InnoModels Bioengineering Homology Model Platform constructs gene sequence models with homology to target organisms through sequence comparison and analysis of biological genomes. The platform can not only be used for the study of gene function, but also provide an accurate and reliable modeling basis for drug development, disease prevention and treatment.
Platform advantages:
1. Accuracy: Genetic engineering homology models are based on sequence comparison and analysis of genomes, which can more accurately reflect the real genomic information of organisms. This makes the platform highly accurate in drug target screening, validation and disease pathogenesis research, providing strong support for research in the field of biomedicine.
2. Reproducibility: Since the genetically engineered homology model is constructed based on the homology of the genome, consistent results can be obtained in different laboratories and studies. This high degree of reproducibility ensures the reliability of the research results and lays the foundation for a wide range of applications in the fields of drug development, disease prevention and treatment.
3. Applicability: The genetically engineered homology modeling platform has wide applicability and can be applied to a wide range of organisms, including humans, animals and plants. This provides a broader space for research in the field of biomedicine and helps to promote the comprehensive development of the field.

 


Application fields:
1. Drug R&D: The genetic engineering homology modeling platform can be used for screening and validation of drug targets, providing more precise guidance for the development of new drugs. Through the platform, researchers can find potential drug targets faster, shorten the drug development cycle and improve the efficiency of research and development.
2. Disease prevention and treatment: The platform can also be used to study the pathogenesis of diseases and the mechanism of drug action, providing new ideas and methods for disease prevention and treatment. Through in-depth study of the genetic basis of diseases, researchers can more accurately predict the occurrence and development trend of diseases, and provide strong support for the early prevention and treatment of diseases.
3. Genetic research: Genetic engineering homology modeling platform also plays an important role in the field of genetic research. Through in-depth study of the genome, researchers can better understand the pathogenesis of genetic diseases and provide new methods and means for the diagnosis and treatment of genetic diseases.
Conclusion:
Genetically engineered homology modeling platform of InnoModels Biotechnology plays an important role in the field of biomedicine with its accuracy, reproducibility and wide applicability. The platform provides strong support for drug discovery and development, disease prevention and treatment, genetics research and other fields, and helps to promote the overall development of the biomedical field. In the future, with the continuous development and improvement of genomics technology, the application prospect of the genetic engineering homology model platform will be even broader. We are looking forward to more breakthroughs in the field of biomedicine from InnoModels Biotechnology and making greater contributions to the cause of human health.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司